Measurements of Transcutaneous Oxygen Pressure and Changes in Blood Rheology as Markers of Prognosis of Critically Ischemic Limb in Diabetes Mellitus Patients
Restricted accessOtherFirst published online March, 2003
Measurements of Transcutaneous Oxygen Pressure and Changes in Blood Rheology as Markers of Prognosis of Critically Ischemic Limb in Diabetes Mellitus Patients
The aims of this study were to compare variations of the transcutaneous oxygen pressure (TcPO2) and blood rheology in diabetic patients. Diabetic patients with critical limb ischemia were compared with those who were either asymptomatic or had mild peripheral vascular disease (PVD). The results showed a significant decrease in TcPO2 in patients with critical limb ischemia. Low shear rate blood viscosity, red blood cell (RBC) aggregation, plasma viscosity, and fibrinogen level were significantly higher in the group with critical severe limb ischemia. The group with critical limb ischemia was subdivided on the basis of clinical outcomes after 1 year and the prognostic values of these measurements examined. A TcPO2 value of 10 mm Hg was associated with a positive predictive value of 94%. RBC aggregation index and fibrinogen levels offered positive predictive values of 89% and 88%, respectively, when cut off values were derived from means + 1 SD of same parameters in patients with asymptomatic or mild PVD. TcPO2 is useful to follow the deterioration of diabetics with critical limb ischemia.
Get full access to this article
View all access options for this article.
References
1.
1. Edmonds M, Watkins P. The diabetic foot. In: Alberti KGMM, De Fronzo RA, Kenn H, Zimmet P, editors. International text book of diabetes mellitus. Chichester, UK: Wiley ; 1992. p. 1535-1548.
2.
2. Boyko E, Ahroni J, Smith D, et al. Increased mortality associated with diabetic foot . Ulcer Diabet Med1996;13: 967-972 .
3.
3. Flynn M, Tooke J. Microcirculation and the diabetic foot . Vasc Med Rev1990;1: 121-138 .
4.
4. Jaap A, Tooke J. Is microvascular disease important in the diabetic foot? In: Bouton AJM, Conner H, Cavanagh PR, editors. The foot in diabetes. 2nd ed. New York: John Wiley ; 1994. p. 49-56.
5.
5. Bongard O, Fagrell B. Discrepancies between total and nutritional skin microcirculation in patients with peripheral arterial occlusive disease . VASA1990;19: 105-111 .
6.
6. Ubbink D, Jacobs M, Slaaf D, et al. Microvascular reactivity differences between the two legs of patients with unilateral lower limb ischaemia . Eur J Vasc Surg1992;6: 269-275 .
7.
7. Zimmy S, Dessel F, Ehren M, et al. Early detection of microcirculatory impairment in diabetic patients with foot at risk . Diabetes Care2001;10: 1810-1814 .
8.
8. Franzeck U, Talke P, Bernstein E, et al. Transcutaneous PO2 measurements in health and peripheral arterial occlusive disease . Surgery1982;91: 156-163 .
9.
9. Sheffield P. Measuring tissue oxygen tension: a review . Undersea Hyperb Med1998;25: 179-188 .
10.
10. Ubbink D, Jacobs M, Tangelder G, et al. The usefulness of capillary microscopy, transcutaneous oxymetry and laser Doppler fluxmetry in the assessment of the severity of lower limb ischaemia . Int J Microcir1994;14: 34-44 .
11.
11. Padberg F, Back T, Thompson P, et al. Transcutaneous oxygen estimates probability of healing in the ischemic extremity . Int Surg Res1996;60: 365-369 .
12.
12. Dwars B, Van den Brock T, Rauwerda J, et al. Criteria for reliable selection of the lowest level of amputation in peripheral vascular disease . J Vasc Surg1992;15: 536-542 .
13.
13. Ubbink D, Jacobs M, Spincemaille J, et al. Prediction of imminent amputation in patients with non reconstructible leg ischemia by means of microcirculatory investigations . J Vasc Surg1999;30: 114-121 .
14.
14. Kalani M, Östergren J, Brismar K, et al. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers . Diabetes Care1999;22(1): 147-151 .
15.
15. Barnes A. Rheology of diabetes mellitus. In: GDO Lowe, editor. Clinical blood rheology. Vol 1. Boca Raton: CRC Press ; 1988. p. 163-187.
16.
16. Mac Rury S, Lowe G. Blood rheology in diabetes mellitus . Diabet Med1999;7: 285-291 .
17.
17. Le Dévéhat C, Khodabandehlou T, Vimeux M. Diabète sucré et fibrinogène: conséquences hémorhéologiques et microcirculatoires . J Mal Vasc2000;25(1): 53-57 .
18.
18. Khodabandehlou T, Le Dévéhat C. Evaluation de la déformabilité érythrocytaire par analyseur du temps de transit cellulaire “CTA.” Comparaison avec la technique du débit initial de filtration. Application à des sangs de patients diabétiques . J Mal Vasc1996;21(3): 175-180 .
19.
19. Boisseau M. Existe-t-il des marqueurs rhéologiques de mauvais pronostic au cours de l'artériopathie diabétique? J Mal Vasc2001;26(2): 117-121 .
20.
20. Mac Rury S, Lockhart J, Small M, et al. Do rheological variables play a role in diabetic peripheral neuropathy? Diab Med1991;8: 232-236 .
21.
21. Zioupos P, Barberel J, Lowe G, et al. Foot microcirculation and blood rheology in diabetes . J Biomed Eng1993;15: 155-158 .
22.
22. Jay R, Jones S, Hill C, et al. Blood rheology and cardiovascular risk factors in type 1 diabetes: relationship with microalbuminuria . Diab Med1991;8: 662-667 .
23.
23. Mac Rury S, Lennie S, Mac Coll P, et al. Increased red cell aggregation in diabetes mellitus: association with cardiovascular risk factors . Diab Med1993;10: 21-26 .
24.
24. Bode W. Fonk T, Van der Veen E, et al. Blood viscosity in diabetic retinopathy . Neth J Med1985;28: 449-453 .
25.
25. Bauduceau B, Renaudeau C, Mayaudon H, et al. Modification des paramètres hémorhéologiques au cours des complications microangiopathiques du diabète . Diab Metab1995;21: 188-193 .
26.
26. Demiroglu H, Gurlek A, Barista I. Enhanced erythrocyte aggregation in type 1 diabetes with late complications . Exp Clin Endo Diab1999;107: 35-39 .
27.
27. Schut N, Van Arkel E, Hardeman M, et al. Blood and plasma viscosity in diabetes: possible contribution to late organ complications? Diab Res1992;19: 31-35 .
28.
28. Zimmermann J, Schramm L, Wanner C, et al. Hemorheology plasma protein composition and Von Willebrand factor in type 1 diabetic nephropathy . Clin Nephrol1996;46(4): 230-236 .
29.
29. Jörneskog G, Djavani K, Brismar K. Day-to-day variability of transcutaneous oxygen tension in patients with diabetes mellitus and peripheral arterial occlusive disease . J Vasc Surg2001;34(2): 277-282 .
30.
30. Donner M, Siadat M, Stoltz J. Erythrocyte aggregation: approach by light scattering determination . Biorheology1989;25: 367-375 .
31.
31. Chabanel A, Samama M. Evaluation of a method to assess red blood cell aggregation . Biorheology1989;26: 785-797 .
32.
32. Got I. La pression transcutanée d'oxygène (TcpO2): intérêts et limites . Diabetes & Metabolism1998;24: 379-384 .
